EUVIMEDEUVIMED entdecken
Crossref

Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common

Leah T Braun iD, Frederick Vogel iD, Elisabeth Nowak iD, German Rubinstein iD, Stephanie Zopp, Katrin Ritzel iD, Felix Beuschlein iD, Martin Reincke iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Leah T Braun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik IV, LMU University Hospital, LMU Munich 80336, Germany. Hauptthemen laut MEDLINE: Cushing Syndrome, Hydrocortisone. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: German Cushing's Registry CUSTODES, Else Kröner-Fresenius Stiftung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cushing's syndrome (CS) can be difficult to diagnose. A timely diagnosis, however, is the cornerstone for targeted treatment, to reduce morbidity and mortality. One reason for the difficulties to identify early on patients with CS might be the presence of a mild phenotype. The aim of the study was to classify the phenotypic landscape of CS. We studied patients with overt CS and mild autonomous cortisol secretion (MACS).

Method

The study was part of the German Cushing's registry. Patients were prospectively included at time of diagnosis and the number of comorbidities and clinical signs and symptoms were assessed in a standardized fashion. One hundred twenty-nine patients with CS (pituitary CS, n = 85, adrenal CS, n = 32, ectopic CS, n = 12, respectively) and 48 patients with MACS were included. Patients with clinical signs and/or comorbidities typical for CS and at least 2 pathological screening tests were classified as having CS. Patients with a 1 mg low-dose-dexamethasone-suppression test above 1.8 µg/dL without being clinically overt CS were classified as having MACS.

Results

On average, patients with CS had 2 comorbidities (range 1-3) at time of diagnosis (pituitary CS: 2 [1-3], adrenal CS: 3 [2-4], ectopic CS: 3 [2-4]). Patients with MACS, however, had 3 comorbidities (range 2-3). Hypertension was the most common comorbidity in all subtypes of CS (78%-92%) and in patients with MACS (87%). Of a total of 11 clinical signs, patients with CS had on average 5 with 28% of patients having between 0 and 3 clinical signs, 50% 4-7 signs, and 22% more than 7 clinical signs. Patients with MACS had on average 2 clinical signs (range 1-3) at time of diagnosis.

Conclusion

The phenotypic landscape of CS is quite variable. The frequency of comorbidities is similar between patients with CS and MACS. A relevant number of patients with overt CS have just a few clinical signs. There is also an overlap in frequency of symptoms and clinical signs between patients with CS and MACS. According to the current guidelines, 96% of our patients with MACS fall into the category “consideration of adrenalectomy”. This should be kept in mind when making treatment decisions in the latter group of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeHydrocortisoneHumansMaleFemaleMiddle AgedAdultAgedYoung AdultProspective StudiesRegistriesComorbidityGermanyAdolescent

Stichwörter der Autor:innen

ACTHCushing's diseasecortisolsubclinical Cushing's syndrome

Substanzen

Hydrocortisone

Autor:innen und Institutionen

  • Medizinische Klinik und Poliklinik IV, LMU University Hospital, LMU Munich 80336, Germany.
  • Department of Endocrinology, Diabetology, and Clinical Nutrition, University Hospital Zürich (USZ) and University of Zurich (UZH), Zurich 8091, Switzerland.
  • The LOOP Zurich-Medical Research Center, University of Zurich, ETH Zurich, Zurich 8044, Switzerland.

ORCID-Profile: Leah T Braun, Frederick Vogel, Elisabeth Nowak, German Rubinstein, Katrin Ritzel, Felix Beuschlein, Martin Reincke

Förderung

  • German Cushing's Registry CUSTODES
  • Else Kröner-Fresenius Stiftung
  • Deutsche Forschungsgemeinschaft
  • DFG
  • German Research Foundation
  • Clinical Research Priority Program
  • University of Zurich
  • CRPP HYRENE

Zitieren

APA

Braun, L. T., Vogel, F., Nowak, E., Rubinstein, G., Zopp, S., Ritzel, K., Beuschlein, F., & Reincke, M. (2024). Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae127

Vancouver

Braun LT, Vogel F, Nowak E, Rubinstein G, Zopp S, Ritzel K, et al. Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae127

BibTeX
@article{Braun2024,
  author = {Braun, Leah T and Vogel, Frederick and Nowak, Elisabeth and Rubinstein, German and Zopp, Stephanie and Ritzel, Katrin and Beuschlein, Felix and Reincke, Martin},
  title = {Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae127}
}
Kostenlos starten →